#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease recurrent Paroxysmal nocturnal haemoglobinuria Diffuse large B-cell lymphoma recurrent Barth syndrome Breast cancer metastatic Duchenne muscular dystrophy Dupuytren's contracture Anal fistula Pleomorphic leiomyosarcoma Diffuse large B-cell lymphoma refractory Thalassaemia alpha Congenital cystic kidney disease Diffuse large B-cell lymphoma Penile cancer Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome Lennox-Gastaut syndrome – Diagnostics Glycogen storage disease type I – Treatment Urea cycle disorder – Treatment Ewing’s sarcoma – Life with Disease Niemann-Pick disease – Trials in Disease Factor IX deficiency Fragile X syndrome – Diagnostics Usher’s syndrome – Diagnostics Wiskott-Aldrich syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tilmanocept Gebasaxturev Human Normal Immunoglobulin Depemokimab Diazepam Aminocaproic Acid Romosozumab Ezabenlimab Rbl005.3 Rbl016.2 Ribonucleic Acid K10 Munc-Cd34 Inavolisib SODIUM FUSIDATE Flecainide Ampreloxetine Fosinopril Sodium Rilvegostomig Mirtazapine Abc-23B-116 More therapies…

    Learn about Your Condition

    Metastases to lymph nodes Osteosarcoma metastatic Glanzmann's disease Papillary thyroid cancer Lung adenocarcinoma Elderly Open angle glaucoma Bronchiectasis Major depression Dementia Alzheimer's type Desmoplastic melanoma Mixed dementia Psoriatic arthropathy Ewing's sarcoma Acne More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Itraconazole and Nebulised Amphotericin B with Itraconazole Alone for Patients with Chronic Pulmonary Aspergillosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary aspergillosis
    Investigated Drugs:
    • Amphotericine B, Liposome
    • Voriconazole
    • Posaconazole
    France

  • Study on the Effectiveness of CL-AD-MSC-002 Injections for Dry Mouth in Patients with Sjögren’s Syndrome

    Recruiting

    1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Cl-Ad-Msc-002
    Denmark

  • Study on Landiolol Hydrochloride and Sodium Chloride for Reducing Mortality in Patients with Septic Shock and High Heart Rate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Landiolol Hydrochloride
    • Sodium Chloride
    France

  • Study on Hydroxychloroquine for Patients with Cutaneous Mastocytosis or Indolent Systemic Mastocytosis with Skin Involvement

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mastocytosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    France

  • Study on Tasquinimod for Patients with Myelofibrosis Who Are Refractory or Intolerant to JAK2 Inhibitors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Primary myelofibrosis
    • Myelofibrosis
    Investigated Drugs:
    • Tasquinimod
    Germany The Netherlands

  • Study on Gemcitabine for Patients with Recurrent Glioblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    • Glioblastoma
    Investigated Drugs:
    • Gemcitabine
    Norway
Previous Page
1 … 620 621 622 623 624 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!